A team led by Professor Mitch Dowsett, Head of Biochemistry at The Royal Marsden NHS Foundation Trust, based in London and Surrey, together with colleagues from the USA, Switzerland and Italy carried out an international, web-based consultation to identify the most pressing issues that could be tackled by translational research. Translational research - which is concerned with the transfer of findings from the lab to the clinic - holds huge promise for the individualisation of cancer treatment.
In this study, a database of over 4000 potential participants (breast cancer professionals, including clinicians, research scientists, academics and pathologists) was created using attendee details from two major breast cancer conferences, one held in the USA and one in Europe. Participants were asked to register online and then log the most important questions that they felt the research community should tackle.
A steering committee reduced the 409 questions registered to 70 unique issues, from which participants were asked to vote for their 'top six'. In all, 420 participants from 48 countries voted; around half of voters classed themselves as clinicians.
The top research priority found was the identification of molecular signatures to select patients who could be spared chemotherapy. The second most pressing issue also involved chemotherapy, namely the identification of features to help clinicians choose the optimal chemotherapy regimen for individual patients.
While translational research in breast cancer has increased greatly over recent years, individual projects often reflect the immediate interests of the research group, rather than attempting to answer a specific question with potential to alter patient management. Identifying issues deemed important by the research community could help focus translational research resources, ensuring that opportunities for important clinical advances aren't missed.
"This appears to be a novel way to identify the most important challenges for improving breast cancer treatment and prevention" explains Professor Dowsett. "The work will allow investigators globally to select the most relevant clinical research questions in their efforts to translate the major advances in basic science to improvements in the clinical management of this common malignancy. I am grateful to the participants from 48 countries who made this possible."
Charlotte Webber | alfa
Purdue cancer identity technology makes it easier to find a tumor's 'address'
16.11.2018 | Purdue University
Microgel powder fights infection and helps wounds heal
14.11.2018 | Michigan Technological University
Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.
Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...
Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.
Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...
Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.
In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...
On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.
When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure
Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...
09.11.2018 | Event News
06.11.2018 | Event News
23.10.2018 | Event News
16.11.2018 | Health and Medicine
16.11.2018 | Life Sciences
16.11.2018 | Life Sciences